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Abstract
Objective—To compare bone mass between overweight adolescents with and without
cardiometabolic risk factors (CMR). Associations of bone mass with CMR and adiposity were
also determined.
Study design—Overweight adolescents (aged 14–18 years) were classified in Healthy (n=55),
1CMR (n=46) or ≥2CMR (n=42). CMR were measured using standard methods and defined
according to pediatric definitions of metabolic syndrome. Total body bone mass, fat mass and fat-
free soft tissue mass (FFST) were measured by DXA. Visceral adipose tissue (VAT) and
subcutaneous abdominal adipose tissue (SAAT) were assessed using MRI.
Results—After controlling for age, sex, race, height and FFST, Healthy group had 5.4% and
6.3% greater bone mass than the 1CMR and ≥2CMR groups, respectively (both P<0.04). Multiple
linear regression, adjusting for same covariates, revealed that VAT (β=−0.22), waist
circumference (β= −0.23), homeostasis model assessment of insulin resistance (β= −0.23) and
HDL-cholesterol (β=0.22) were associated with bone mass (all P<0.04). There was a trend
towards a significant inverse association between bone mass and fasting glucose (P=0.056). No
relations were found between bone mass and fat mass, SAAT, BP or triglycerides.
Conclusion—Being overweight with metabolic abnormalities, particularly insulin resistance,
low HDL-cholesterol and visceral adiposity, may adversely influence adolescent bone mass.
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Peak bone mass, which is generally achieved by early adulthood, is an important
determinant of adult risk for osteoporosis. Hence, any childhood disease or condition that
reduces bone mineral accrual during the maturational period may lead to suboptimal peak
bone mass and presumably a greater risk of fracture in later life.1 Recently, there has been a
growing concern that childhood obesity may negatively affect bone development, as there is
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evidence linking childhood obesity to skeletal fractures.2 However, determining whether
excess adiposity is either beneficial or detrimental to the growing skeleton has been
challenging. Whereas some studies report greater bone mass in overweight children and
adolescents compared with their healthy weight peers,3–5 others conclude that obesity is
linked to lower bone mass or that extra weight from fat mass had no effect on bone mass.6–9
Discrepancies in the aforementioned childhood bone-fat investigations may be attributed, in
part, to the methodological limitations when comparing bone mass between overweight and
healthy weight children of the same age. At any given age, a wide variation exists among
children in stature, body composition, rate of growth, and timing and tempo of biological
maturation. Because overweight compared with healthy weight children of the same age are
generally further advanced in maturation, their skeletal development is likewise more
advanced, because of increased hormonal activity, than their healthy weight peers. In
addition, the metabolic effects of obesity could have an impact on bone development.
Currently, no studies have investigated the bone-fat relationship in overweight youth, while
considering cardiometabolic risk factors (CMR).
The primary aim of this study was to compare total body bone mineral content (BMC)
between overweight adolescents with no CMR (Healthy group), adolescents with only one
CMR (1CMR group), and adolescents with two or more CMR (≥2CMR group). The
secondary aim was to determine associations of total body BMC with CMR and robust
measurements of total and central adiposity. We tested the hypotheses that: 1) total body
BMC is lower in the overweight adolescents with CMR, and 2) total body BMC is
negatively associated with CMR and central adiposity. Because age, sex, race, height, and
muscle mass are known to be independent predictors of bone mass in children and
adolescents,18 these variables were considered as potential confounders in our analyses.
METHODS
Participants in this cross-sectional investigation were 143 overweight adolescents that were
recruited from high schools in Augusta, Georgia area to participate in an adiposity and
cardiovascular fitness study. With approval from superintendents and school principals,
flyers were distributed to all students in the high schools. Inclusion criteria for this study
were the following: white or black/African-American race, aged 14–18 years, and
overweight (BMI ≥ 85th percentile for age and sex). Adolescents were excluded if they were
taking medications or had any medical conditions that could affect growth, maturation,
physical activity, nutritional status, or metabolism. Informed consent and assent were
obtained from all parents and adolescents, respectively. The protocol was approved by the
Human Assurance Committee at the Medical College of Georgia (Institutional Review
Board). All measurements were performed at the Georgia Prevention Institute at the Medical
College of Georgia between 2001 and 2005.
Height, body weight, and waist circumference measurements were collected by a trained
laboratory technician. Participants were measured in light indoor clothing after the removal
of shoes. Height (cm) and body weight (kg) were assessed for calculation of sex- and age-
specific BMI percentiles.19 Waist circumference (cm) was then obtained at the midpoint
between the lowest rib and the iliac crest. Seated blood pressure was measured 5 times at 1
min intervals after a 10-minute rest using the Dinamap Pro 100 (Critikon Corporation,
Tampa, FL), and the last 3 measures were averaged. Sexual maturation stage (or Tanner
stage) was measured using a five-stage scale, ranging from I (prepubertal) to V (fully
mature) as described by Tanner.20 Using a sex-specific questionnaire, participants reported
their pubertal stage by comparing their own physical development to the five stages in
standard sets of diagrams. A parent or research coordinator then reviewed the results with
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the children to make sure they understood the questionnaire. When an individual reported
discordant stages of pubic hair and breast or genital development, the higher of the two
stages was used. In addition, the females provided information about their menarcheal
status.
Fasting blood samples were obtained from participants for assessment of glucose, insulin,
triglycerides, total cholesterol, HDL-cholesterol, and LDL-cholesterol. Glucose was
measured in 10 μL sera using an Ektachem DT system (Johnson and Johnson Clinical
Diagnostics, Rochester, NY) with mean intra- and interassay CVs of 0.61% and 1.45%,
respectively. Insulin was assayed in duplicate 100 μL with reagents obtained from Linco
(St. Charles, MO) with mean intra- and interassay CVs of 5% and 5.6%, respectively. From
the measures of glucose and insulin, the homeostasis model assessment of insulin resistance
(HOMA-IR) was calculated: fasting insulin (μU/mL) x fasting glucose (mg/dL)/405.
Triglycerides (mg/dL), total cholesterol (mg/dL), and high-density lipoprotein cholesterol
(HDL; mg/dL) were measured with the Ektachem DT II system. With this system, HDL-
cholesterol is analyzed using a two-reagent system involving stabilization of low-density
lipoprotein, very-low-density lipoprotein, and chylomicrons using cyclodextrin and dextrin
sulfate, and subsequent enzymatic-colorimetric detection of HDL-cholesterol. Low-density
lipoprotein cholesterol (LDL; mg/dL) was determined using the Friedewald formula.
Bone outcomes of the total body [BMC (g), bone area (cm2) and aBMD (g/cm2)] were
measured using dual-energy X-ray absorptiometry (DXA; QDR-4500W, Hologic Waltham,
MA). Because of the limitations of aBMD in children and adolescents, total body BMC has
been proposed as the most appropriate outcome measure of bone mass status in youth.21
Therefore, total body BMC was chosen as our primary bone outcome measure for bone mass
status. Total body composition was also determined by DXA for fat-free soft tissue mass
(FFST, kg) and fat mass (kg). Anthropomorphic phantoms were scanned daily for quality
assurance. In this laboratory, using a one-way random effects model, single measure
intraclass correlation coefficients (ICC) were calculated in 219 adolescents, aged 13–18 y.
Each participant was scanned twice within a 7-day period for BMC, bone area, aBMD,
FFST mass, and fat mass (all R ≥ 0.97).
Visceral adipose tissue (VAT) and subcutaneous abdominal adipose tissue (SAAT) were
measured using a 1.5-T magnetic resonance imaging system (MRI, General Electric Medical
Systems, Milwaukee, WI). Five transverse images were acquired from the lumbar region
beginning at the inferior border of the fifth lumbar vertebra and proceeding toward the head;
a 2-mm gap between images was used to prevent crosstalk. To calculate volumes for VAT
and SAAT, the cross-sectional area (cm2) from each slice was multiplied by the slice width
(1 cm) and then the individual volumes (cm3) were summed. The ICCs for repeat analyses
of the same scans on separate days within a 7-day period were R ≥ 0.98 for both VAT and
SAAT.
The amount of minutes per day spent in moderate and vigorous physical activities (PA) were
assessed using MTI Actigraph monitors (model 7164; MTI Health Services, Fort Walton
Beach, FL), uniaxial accelerometers that measure vertical acceleration and deceleration.
With epoch length set at 1 minute and expressed as counts per minute, the accelerometers
were to begin recording when the subject left our laboratory after the first day of testing. The
subjects were instructed to 1) wear the monitor for a period of 7 days, 2) remove it for sleep,
bathing, and any activity that may cause harm to either the monitor or another person (e.g.,
during contact sports), and 3) bring the monitor back to us 1 week later. Data from day 1 and
day 7 were discarded because a full day of information was not available for those days.
Movement counts were converted to average minutes per day spent in moderate [3–6
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metabolic equivalents (METs)] and vigorous (>6 METs) PA by the software accompanying
the device.
To assess mean daily intakes for energy (kcal), dietary calcium (mg/d), dietary vitamin D
(μg), and the percentage of kcal/d from carbohydrates, protein, and fat, a trained registered
dietitian conducted four to seven 24-h recalls (including 1 weekend day) using a multiple
pass, computer-assisted interview approach [Nutrition Data System for Research (NDS-R),
Nutrition Coordinating Center, University of Minnesota, Minneapolis, MN]. Four, five, six,
and seven days of dietary information were collected in 10%, 21%, 27%, and 42% of the
adolescents, respectively, within four weeks of the blood collection. The first two recalls
were performed in person at our institute with the use of food models, portion booklets, or
serving containers to assist in estimating serving size, and the remaining interviews were
conducted by telephone. Participants were not interviewed on days when they had been ill,
or days that fell on a major holiday. To minimize the potential for under eating during the
time frame for 24-h recalls, youths were blinded to the telephone recall schedule. A trained
research assistant coded and analyzed dietary intake data using NDS-R software version
2006 (Nutrition Coordinating Center, University of Minnesota, Minneapolis, MN).
For this analysis, the majority of CMR were defined according to the National Cholesterol
Education Program Adult Treatment Panel III definition modified for age.22 These risk
factors were defined accordingly: (1) waist circumference ≥90th percentile for age and sex;23
(2) HDL cholesterol ≤40 mg/dL; (3) triglycerides ≥110 mg/dL; (4) systolic or diastolic
blood pressure ≥90th percentile for age, sex, and height;24 and (5) fasting glucose ≥100 mg/
dL.25
Statistical Analyses
Data were checked for outliers and for normality using histograms and tests of skewness and
kurtosis for normality. Insulin, HOMA-IR, and triglycerides were log-transformed so that
each of these variables followed an approximate normal distribution. Because the results in
the log-transformed models and untransformed models were similar, we report the
untransformed data in Table I for clarity. We used analysis of covariance (ANCOVA) to
compare descriptive characteristics between the three overweight groups, adjusting for age
and sex. Differences in proportions were tested by the chi-square test of goodness of fit.
For comparison of the bone variables, an F test was performed to test the assumption of
homogeneity of regression slopes for the interaction between the independent variables (i.e.,
Healthy, 1CMR, and CMR groups) and the covariates (age, sex, race, height and FFST
mass). Because there was no interaction, ANCOVA was used to compare the bone variables
between the Healthy, 1CMR, and ≥2CMR groups after adjusting for sex, race, height, and
FFST mass. The Least Square Difference method was used to adjust for multiple
comparisons and statistical differences are shown between each pair (Healthy vs. 1CMR,
Healthy vs. ≥2CMR, and 1CMR vs. ≥2CMR). In the total sample, stepwise linear regression
analysis was performed to identify independent correlates of total body BMC using the
stepwise procedure. The variables with P < 0.05 in the hierarchical multiple regression
model (using the covariates of age, sex, race, height, and FFST mass) were then entered in
the stepwise multiple regression model. All statistical analyses were performed using SPSS
version 18.02 for Mac OS X (PASW Statistics, Chicago, IL). A P-value < 0.05 was
considered statistically significant for all analyses.
RESULTS
The sample was composed of 143 white and black adolescents, aged 14–18 years, with an
approximately equal distribution of females (52%) and males (48%), (χ2 = 0.18, P = 0.68).
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Although there were a greater percentage of blacks (59%) than whites (41%), the racial
distribution was not significantly different between females and males (χ2 = 1.87, P = 0.17).
The majority of participants (91%) reported to be in pubertal stages IV and V; however, 10
subjects reported to be in pubertal stage III and three in stage II. All females reported having
started menstruation. Of the 143 overweight adolescents, 62% were identified with at least
one cardiometabolic risk factor, and the number of participants with one, two, three and four
cardiometabolic risk factors was 46, 30, 11, and 1, respectively. The cardiometabolic risk
factor distributions among the participants were the following: 24% (n = 35) with waist
circumference ≥90th percentile for age and sex; 8% (n = 11) and 0% with systolic and
diastolic blood pressure ≥90th percentile for age, sex, and height, respectively; 10% (n = 15)
with fasting glucose ≥100 mg/dL; 15% (n = 22) with triglycerides ≥110 mg/dL; and 42% (n
= 60) with HDL-cholesterol ≤40 mg/dL.
The descriptive characteristics of the three overweight groups (i.e., Healthy, 1CMR, and
≥2CMR groups) are shown in Table I. Height, weight, BMI percentile, FFST mass, fat mass,
waist circumference, VAT, systolic BP, fasting insulin, and HOMA-IR were significantly
lower and HDL-cholesterol were significantly higher in the Healthy group compared with
the 1CMR and ≥2CMR groups (all P < 0.05, Table I). The CMR group vs. ≥2CMR group
had significantly lower body weight, BMI percentile, fat mass, waist circumference, VAT,
SAAT, fasting glucose, HOMA-IR, and triglycerides and significantly higher HDL-
cholesterol (all P < 0.05). Age, Tanner stage, total body BMC, total body bone area, total
body aBMD, diastolic BP, total cholesterol, moderate and vigorous PA, and the dietary
variables were not statistically different between Healthy, 1CMR, and ≥2CMR groups (all P
> 0.05).
Bone Comparisons between Groups
Group-specific means for each bone variable based on analysis of covariance that controls
for age, sex, race, height and FFST mass are shown in Figure 1. After controlling for
covariates, total body BMC was 5.4% higher in the Healthy vs. 1CMR (P = 0.018) and 6.3%
greater in the Healthy vs. ≥2CMR (P = 0.007). Total body aBMD was 4.3% greater in the
Healthy vs. 1CMR (P = 0.036) and 5.2% higher in the Healthy vs. ≥2CMR (P = 0.006).
There were no significant differences in total body bone area between groups.
Associations of Total BMC
Multiple linear regression, adjusting for age, sex, race, height and FFST mass, revealed that
VAT was negatively associated with total body BMC, and it could explain 4.8% of the
variation in total body BMC (Figure 2, B, P = 0.037). The other adiposity variables, fat mass
and SAAT, were not significantly associated with total body BMC (Figure 2, A and C).
Multiple linear regression analyses were also conducted to investigate whether total body
BMC was associated with CMR, PA, and dietary variables among all subjects, after
adjustment for age, sex, race, height and FFST mass. Waist circumference (standardized β =
−0.23), fasting insulin (standardized β = −0.23), and HOMA-IR (standardized β = −0.26)
were negatively associated with total body BMC (all P < 0.02). Similarly, there was a trend
towards a significant, negative association between total body BMC and fasting glucose
(standardized β = −0.21, P = 0.056) and total cholesterol (standardized β = −0.11, P =
0.067). Conversely, HDL-cholesterol (standardized β = 0.22) and energy intake
(standardized β = 0.20) were positively associated with total body BMC (both P < 0.05).
There were no significant associations between total body BMC and systolic BP, diastolic
BP, triglycerides, LDL-cholesterol, moderate PA, vigorous PA, moderate + vigorous PA,
dietary calcium intake, or dietary vitamin D intake.
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Table II displays the stepwise multiple linear regression that was conducted to examine the
independent association of age, sex, race, height, FFST mass, VAT, HOMA-IR, HDL-
cholesterol and energy intake with total body BMC. Sex (5.2%), race (1.3%), height (1.2%),
FFST mass (69.2%) and HOMA-IR (4.1%) explained a total of 81% of the variance in total
body BMC, with no contribution by age, VAT, HDL-cholesterol and energy intake.
DISCUSSION
Our findings suggest that if cardiometabolic risk factors are present alongside being
overweight, it could have a negative effect on bone. More importantly, it is possible to
hypothesize that if the extra weight from fat mass provides no additional influence to bone,
an overweight adolescent with metabolic abnormalities may be more susceptible to fracture
because traumatic impact forces generally scale with body weight. However, further work is
required to establish this connection.
Even in adults, the associations of metabolic syndrome with bone mass have not been
extensively explored, and the results have been mixed. Whereas some authors have reported
greater bone mass in adults with metabolic syndrome,26 others have shown the opposite
relationship.12, 13 These conflicting reports may be due, in part, to the heterogeneous
samples studied (e.g. age, co-morbid disease status and medication use) and potentially of
greater importance, the lack of consideration of the generally larger body size in metabolic
syndrome patients compared with controls. If the latter is not considered, the effect of body
size on bone mass could lead to misinterpretations when comparing individuals of different
stature and body composition. In this study, we sought to minimize the confounding effects
of body size on bone mass by making comparisons solely between overweight adolescents,
and by statistically controlling for height and FFST mass, thus separating the effect of fat
mass on bone.
Recent studies have challenged the traditionally accepted view that obesity is beneficial to
the growing skeleton;6–9 however, it is apparent that a phenotype, beyond total fat
accumulation, is needed to explain the complex relationship between developing bone and
obesity. Given that HOMA-IR in this study explained a significant proportion of the
variance in total body bone mass, it is plausible that insulin resistance may explain, in part,
the association between obesity and suboptimal bone mass. Evidence to support this notion
was first introduced by Afghani el al27 in a cohort of overweight Hispanic-American
children in which total body BMC was inversely associated with markers of insulin
resistance, as determined by oral glucose tolerance test. Similarly, in a recent study of
overweight prepubertal children,28 our group observed lower bone mass in the children with
pre-diabetes compared with the those with normal glucose levels. Taken together, these
studies indicate that abnormal glucose regulation has a negative effect on the growing
skeleton. The mechanism for the potential negative effect of insulin resistance on bone
development is currently unknown; however, some hypotheses include increased calcium
excretion,29 increased concentrations of advanced glycation end-products in collagen,30
disruption in the growth hormone-insulin-like growth factor axis,31 and increased
inflammation.32
It is also possible that obesity during childhood promotes both low bone mass accrual and
risk for diabetes through events that are mechanistically associated. Recent animal data have
uncovered the presence of a “bone-fat-pancreas” axis that regulates energy homeostasis,
coordinates energy partitioning between bone and adipose tissue, and impacts insulin
sensitivity. In mice lacking the gene for osteocalcin, a bone-derived protein and well-known
biomarker of bone formation, Lee et al33 observed phenotypes of glucose intolerance,
insulin resistance, and visceral obesity. When recombinant osteocalcin was administered to
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the animals, improvements in glucose tolerance and insulin secretion were observed.33 In a
mouse model lacking the gene for the insulin receptor in osteoblast (Ob-ΔIR), Fulzele et
al34 demonstrated lower postnatal bone mass acquisition in the Ob-ΔIR mice compared with
controls. Along with decreased bone formation, the Ob-ΔIR mice displayed marked
peripheral adiposity and insulin resistance that was accompanied by decreased osteocalcin
concentrations. When recombinant osteocalcin was administered, the researchers observed
improvements in glucose tolerance and insulin sensitivity.34
The novel relationships described above between osteocalcin and glucose-insulin
metabolism appear to be regulated via leptin,35 an adipocyte-derived hormone that is
strongly and positively correlated with fat mass levels.36 Animal studies reveal that leptin
treatment elicits a bimodal response, where low doses of leptin can stimulate bone formation
and prevent bone loss, but higher concentrations of leptin actually suppress bone formation
and increase bone resorption.37 Thus, one way in which high levels of adiposity may inhibit
the accumulation of bone mass during growth is via hyperleptinemia. Though the basic
mechanisms underlying this biphasic effect are unclear, they may involve leptin receptor
downregulation, which is known to occur with increases in endogenous leptin due to
increased food intake or adiposity.38 Given that obesity, insulin resistance and type 2
diabetes are related disorders of energy metabolism, further investigation of the bone-fat-
pancreas axis is warranted.
Another significant finding in this study was that the influence of adiposity on bone mass
may depend on the manner in which the fat mass accumulates. Given that metabolic
abnormalities are more strongly associated with visceral, rather than subcutaneous,
adiposity, 39 it is possible that the type of fat (visceral vs. subcutaneous) could affect
developing bone distinctly, which could be another potential explanation for the conflicting
pediatric data of the bone-fat relationship. In pediatric investigations, visceral adiposity,
measured by either MRI or computed tomography, has shown to be inversely associated
with bone mass.28, 40, 41 In this study, we found an inverse relationship not only between
VAT and bone mass, but also between waist circumference and bone mass. We did not
observe a significant relationship between SAAT and bone mass. Because waist
circumference is frequently employed as a surrogate for visceral adiposity and is reported to
be more closely associated with negative health outcomes than SAAT or BMI,39 it is
possible that waist circumference may have important clinical utility as an easy and
inexpensive screening tool for assessment of bone health. Whether waist circumference can
be used to predict bone health and risk of skeletal fracture, however, must be validated by
subsequent prospective studies. Nevertheless, our data along with the four aforementioned
pediatric investigations suggest that increased visceral adiposity, which is more clinically
relevant for metabolic abnormalities than increased total body adiposity, could play an
adverse role in bone health.
Modifiable factors such as physical activity and diet not only play an important role in
obesity and metabolic abnormality progression but also impact skeletal development. Thus,
it is possible that differences in bone mass found between groups could be attributed to
dissimilarities in physical activity and diet. In this study, we did not find significant
differences in physical activity between groups; however, the Healthy group performed, on
average, twice as much vigorous physical activity (5.9 vs. 2.9 minutes) than the ≥2 CMR
group. Including vigorous physical activity as a covariate in our analysis did not change any
of our bone outcomes (data not shown). Weight-bearing activity, in general, is known to be
an important determinant of peak bone mass; however, the specific type of exercise,
intensity and duration that will provide the optimal stimulus for peak bone mineral accretion
and metabolic disease diminution still requires further investigation. With regard to dietary
intake, the groups reported no significant differences in energy, macronutrient and
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micronutrient intakes. It is important to note, however, that we found a positive relationship
between energy intake and bone mass in the total sample. Given that our group recently
reported inverse relations between adiposity and energy intake,42 it would seem that trying
to limit energy intake in overweight youth may run counter to the demands of skeletal
growth. Therefore, interventions in overweight children and adolescents may be more
effective if we increase the emphasis on vigorous physical activity and reduce the degree to
which we advise overweight youth to restrict their energy intake.
Our study has several limitations. First, because of our cross-sectional study design, the
associations between bone mass and CMR and VAT do not prove causality. Thus, other
factors such as environmental and inherited may have influenced our findings. Another
limitation was that we utilized only total body DXA-derived bone measurements. Although
specific regional DXA-derived bone data would have provided additional information, the
original intent of this study was not designed to study bone health. Three-dimensional
imaging techniques such as peripheral quantitative computed tomography would afford
more definitive information on volumetric BMD and bone geometry and the effect of
metabolic abnormalities on the individual cortical and trabecular compartments.
Nevertheless, total body BMC is considered one of the preferred bone measurements for the
assessment of bone status in youth, due to its reproducibility, low radiation, and lack of areal
density-related errors.21 More importantly, total body BMC has been shown to be a good
predictor of childhood fracture risk.43 Another important limitation to note is that our small
sample size did not allow separate analysis of data by males and females or by whites and
blacks. Some studies have reported sex and race differences of not only skeletal
development but also of visceral fat accumulation and glucose-insulin metabolism.18, 44
Although determining the effects of metabolic abnormalities on bone mass by sex and race
was not the objective of this study, future work in the area is warranted.
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Mean (± SE total body bone mineral content (BMC), bone area, and mineral density
(aBMD) in overweight adolescents with no cardiometabolic risk factors (CMR) (Overweight
adolescents + Healthy, n=55), overweight adolescents with only one CMR (Overweight + 1
CMR, n=46), and overweight adolescents with two or more CMR (Overweight + ≥2 CMR,
n=42). ■Overall P-value on the basis of ANCOVA, adjusted for age, sex, race, height and
fat-free soft tissue mass. b P <0.05, significantly different from Overweight + Healthy group
(Least square difference adjustment for multiple comparisons.
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Figure 2. Relationship between total body bone mineral content (BMC) and total and central
adiposity in overweight adolescents
(A) Fat mass vs. total body BMC, (B) Visceral adipose tissue (VAT) vs. total body BMC
and (C) subcutaneous abdominal adipose tissue (SAAT) vs. total body BMC. Relationship
are adjusted for age, sex, race, height and far-free soft tissue mass. N = 143
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Table 2
Multiple linear regression model for the dependent variable total body BMC in the total sample of overweight
adolescents (N = 143)
Independent variable b ± SE R2 P valuea
Intercept −1548.9 ± 760.7
Age NS
Sexb −281.9 ± 70.1 5.2% 0.001
Race 133.3 ± 49.2 1.3% 0.030
Height 10.5 ± 5.0 1.2% 0.040
FFST mass 44.1 ± 3.1 69.2% <0.001
Visceral adipose tissue NS




b, unstandardized coefficient; SE, standard error; R2, percentage of variability in total BMC (bone mineral content) that is attributable to the
regression equation. NS, not significant (P > 0.05).
a
Tests of significance were determined by stepwise linear regression at P < 0.05.
b
Sex coded such that male adolescents =1 and female adolescents = 2.
c
Race coded such that white adolescents =1 and black adolescents = 2.
d
HOMA-IR, homeostasis model assessment of insulin resistance
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